AFR vs Saudi Arabia: Estimated antiretroviral therapy coverage among people living with HIV
AFR
83.0%
in 2025
Saudi Arabia
97.0%
in 2025
AFR rank
1st
Saudi Arabia rank
2nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- AFR
- Saudi Arabia
How they compare
Saudi Arabia currently reports 97.0% against 83.0% in AFR, a difference of 14.0%.
That makes Saudi Arabia's figure about 1.2 times AFR's.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Saudi Arabia ahead.
AFR ranks 1st and Saudi Arabia ranks 2nd of 13 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | AFR | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 36.2% | 30.7% | Saudi Arabia |
| 2010s | 46.4% | 50.3% | 3.9% | Saudi Arabia |
| 2020s | 78.0% | 86.2% | 8.2% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, AFR or Saudi Arabia?
- Saudi Arabia, at 97.0% against 83.0% in AFR as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between AFR and Saudi Arabia?
- 14.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for AFR and Saudi Arabia?
- 26 years are reported by both, from 2000 to 2025.
- How do AFR and Saudi Arabia rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- AFR ranks 1st and Saudi Arabia ranks 2nd of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.